https://sputnikglobe.com/20260811/russia-develops-new-treatment-for-medication-induced-rhinitis-1124561215.html
Russia Develops New Treatment for Medication-Induced Rhinitis
Russia Develops New Treatment for Medication-Induced Rhinitis
Sputnik International
An intranasal spray for medication-induced rhinitis, often caused by prolonged overuse of decongestant sprays, has been developed by Russian scientists at Sechenov University.
2026-08-11T10:08+0000
2026-08-11T10:08+0000
2026-08-11T10:08+0000
russia
russia
rospatent
scientists
scientific research
scientific study
medical study
medicine
medics
https://cdn1.img.sputnikglobe.com/img/07e5/0a/1c/1090293996_0:164:3059:1885_1920x0_80_0_0_a9b1eeb59f4e9c8511430ada59b07547.jpg
Its key feature is a mucoadhesive component that keeps the active ingredient on the nasal lining longer, prolonging the therapeutic effect while reducing the risk of systemic side effects. The university says there are currently no equivalent products on the Russian or international markets.The spray has entered preclinical testing, with pilot studies on rats and rabbits confirming its safety and effectiveness. The developers have also filed a patent application with Rospatent.
https://sputnikglobe.com/20260811/russia-makes-full-comeback-in-megascience--scientist--1124559302.html
russia
Sputnik International
+74956456601
MIA „Rossiya Segodnya“
2026
Sputnik International
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
+74956456601
MIA „Rossiya Segodnya“
russia, rospatent, scientists, scientific research, scientific study, medical study, medicine, medics
russia, rospatent, scientists, scientific research, scientific study, medical study, medicine, medics
Russia Develops New Treatment for Medication-Induced Rhinitis
An intranasal spray for medication-induced rhinitis, often caused by prolonged overuse of decongestant sprays, has been developed by Russian scientists at Sechenov University.
Its key feature is a mucoadhesive component that keeps the active ingredient on the nasal lining longer, prolonging the therapeutic effect while reducing the risk of systemic side effects. The university says there are currently no equivalent products on the Russian or international markets.
The spray has entered preclinical
testing, with pilot studies on rats and rabbits confirming its safety and effectiveness. The developers have also filed a patent application with Rospatent.
